Evaluation of bystander cell killing effects in suicide gene therapy of cancer: Engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis

Medicine and Dentistry

• Suicide Gene Therapy 75%
• Cancer Gene Therapy 50%
• Zidovudine 37%
• Cell Killing 37%
• Tumor Cell 25%
• Phosphotransferase 25%
• Solid Malignant Neoplasm 25%
• Lentivirus 25%
• Evaluation Study 25%
• Thymidine Phosphate 25%
• Suicide Gene 25%
• Aptitude 25%
• In Vitro 12%
• Target Cell 12%
• Neoplasm 12%
• Complementary DNA 12%
• Enzyme 12%
• Polypeptide 12%
• Tumor Regression 12%
• Gene Sequence 12%
• Prodrug 12%
• Obstetric Delivery 12%
• Cancer Therapy 12%
• Therapeutic Procedure 12%
• Cells 12%
• Drive 12%

Biochemistry, Genetics and Molecular Biology

• Suicide Gene 100%
• Gene Therapy 75%
• Cell Killing 37%
• Lysozyme 25%
• Solid 25%
• Thymidylate Kinase 25%
• Aptitude 25%
• Lentivirus 25%
• Target Cell 12%
• Gene Sequence 12%
• Drive 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Zidovudine 37%
• Phosphotransferase 25%
• Solid Malignant Neoplasm 25%
• Thymidine Phosphate 25%
• Lentivirus 25%
• Enzyme 12%
• Complementary DNA 12%
• Polypeptide 12%
• Neoplasm 12%
• Tumor Regression 12%
• Enzyme Prodrug Therapy 12%